These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35643926)

  • 21. Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study.
    Husain S; Tollemar J; Dominguez EA; Baumgarten K; Humar A; Paterson DL; Wagener MM; Kusne S; Singh N
    Transplantation; 2003 Jun; 75(12):2023-9. PubMed ID: 12829905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of drugs in adult living donor liver transplant patients: regulatory factors and observations based on studies in animals and humans.
    Li M; Zhao Y; Humar A; Tevar AD; Hughes C; Venkataramanan R
    Expert Opin Drug Metab Toxicol; 2016; 12(3):231-43. PubMed ID: 26809188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted versus universal antifungal prophylaxis among liver transplant recipients.
    Eschenauer GA; Kwak EJ; Humar A; Potoski BA; Clarke LG; Shields RK; Abdel-Massih R; Silveira FP; Vergidis P; Clancy CJ; Nguyen MH
    Am J Transplant; 2015 Jan; 15(1):180-9. PubMed ID: 25359455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic abscesses after liver transplant: 1997-2008.
    Nikeghbalian S; Salahi R; Salahi H; Bahador A; Kakaie F; Kazemi K; Malek-Hosseini SA; Janghorban P
    Exp Clin Transplant; 2009 Dec; 7(4):256-60. PubMed ID: 20353378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug administration in chronic liver disease.
    Westphal JF; Brogard JM
    Drug Saf; 1997 Jul; 17(1):47-73. PubMed ID: 9258630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy.
    Ramsamy Y; Muckart DJ; Han KS
    S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacodynamics and pharmacokinetics of antifungals for treatment of invasive aspergillosis.
    Bellmann R
    Curr Pharm Des; 2013; 19(20):3629-47. PubMed ID: 23278532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis of antibiotics treatment in 86 cases of liver transplant recipients].
    Liu ZG; Gong HY; Zhou JD; Zhang HY
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):852-5. PubMed ID: 19958647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
    Moen MD; Lyseng-Williamson KA; Scott LJ
    Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic interaction between everolimus and antifungal triazoles in a liver transplant patient.
    Pea F; Baccarani U; Tavio M; Cojutti P; Adani GL; Londero A; Baraldo M; Franceschi L; Furlanut M; Viale P
    Ann Pharmacother; 2008 Nov; 42(11):1711-6. PubMed ID: 18812562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population Pharmacokinetics and Dosing Optimization of Vancomycin in Pediatric Liver Transplant Recipients.
    Shoji K; Saito J; Nakagawa H; Funaki T; Fukuda A; Sakamoto S; Kasahara M; Momper JD; Capparelli EV; Miyairi I
    Microbiol Spectr; 2021 Oct; 9(2):e0046021. PubMed ID: 34612690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of risk factors and outcomes of daptomycin-susceptible and -nonsusceptible vancomycin-resistant Enterococcus faecium infections in liver transplant recipients.
    Lewis JD; Barros AJ; Sifri CD
    Transpl Infect Dis; 2018 Jun; 20(3):e12856. PubMed ID: 29427322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biliary amphotericin B pharmacokinetics and pharmacodynamics in critically ill liver transplant recipients receiving treatment with amphotericin B lipid formulations.
    Welte R; Eschertzhuber S; Weiler S; Leitner-Rupprich S; Aigner M; Lass-Flörl C; Stienecke E; Bellmann-Weiler R; Joannidis M; Bellmann R
    Int J Antimicrob Agents; 2015 Sep; 46(3):325-31. PubMed ID: 26119497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should multivisceral transplantation be considered in patients colonized with multidrug-resistant Pseudomonas aeruginosa?
    Florescu DF; Grant W; Botha JF; Fey P; Kalil AC
    Microb Drug Resist; 2012 Feb; 18(1):74-8. PubMed ID: 22107253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients.
    Veiga RP; Paiva JA
    Crit Care; 2018 Sep; 22(1):233. PubMed ID: 30244674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and pharmacodynamics of antifungals.
    Andes D
    Infect Dis Clin North Am; 2006 Sep; 20(3):679-97. PubMed ID: 16984875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of CYP2C19 Genotype and Liver Function on Voriconazole Pharmacokinetics in Renal Transplant Recipients.
    Li ZW; Peng FH; Yan M; Liang W; Liu XL; Wu YQ; Lin XB; Tan SL; Wang F; Xu P; Fang PF; Liu YP; Xiang DX; Zhang BK
    Ther Drug Monit; 2017 Aug; 39(4):422-428. PubMed ID: 28604474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical relevance of pharmacokinetics and pharmacodynamics in cardiac critical care patients.
    Pea F; Pavan F; Furlanut M
    Clin Pharmacokinet; 2008; 47(7):449-62. PubMed ID: 18563954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients.
    Hahn J; Choi JH; Chang MJ
    J Clin Pharm Ther; 2017 Dec; 42(6):661-671. PubMed ID: 28948652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of hepatic CYP3A4 activity on disposition of micafungin in liver transplant recipients with markedly small-for-size grafts.
    Mochizuki N; Matsumoto K; Ohno K; Shimamura T; Furukawa H; Todo S; Kishino S
    Transplant Proc; 2006 Dec; 38(10):3649-50. PubMed ID: 17175357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.